Literature DB >> 24795106

The combination of ribavirin and ozeltamivir effectively inhibits reproduction of influenza A virus resistant to rimantadine (amantadine) in vitro and in vivo.

P G Deryabin1, G A Galegov, I D Konstantinova, I S Muzyka, A I Miroshnikov, D K L'vov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24795106     DOI： 10.1134/S1607672914020100

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  6 in total

1.  Combined action of ribovirin and rimantadine in experimental myxovirus infection.

Authors:  G A Galegov; N L Pushkarskaya; N P Obrosova-Serova; V M Zhdanov
Journal:  Experientia       Date:  1977-07-15

2.  Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.

Authors:  R W Sidwell; J H Huffman; G P Khare; L B Allen; J T Witkowski; R K Robins
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

3.  Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.

Authors:  Jack T Nguyen; Justin D Hoopes; Minh H Le; Donald F Smee; Amy K Patick; Dennis J Faix; Patrick J Blair; Menno D de Jong; Mark N Prichard; Gregory T Went
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

4.  Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.

Authors:  Donald F Smee; Brett L Hurst; Min-Hui Wong; Kevin W Bailey; John D Morrey
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

5.  [Combined action of remantadine (amantadine) and ribavirin on experimental influenza].

Authors:  G A Galegov; V Knight; N L Pushkarskaia; S Z Wilson; R B Couch
Journal:  Vopr Virusol       Date:  1981 Nov-Dec

6.  Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice.

Authors:  Natalia A Ilyushina; Alan Hay; Neziha Yilmaz; Adrianus C M Boon; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191
  6 in total
  2 in total

1.  Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.

Authors:  Charlene Ranadheera; Mable W Hagan; Anders Leung; Brad Collignon; Todd Cutts; Steven Theriault; Carissa Embury-Hyatt; Darwyn Kobasa
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 2.  A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action.

Authors:  Jie Yang; Shuwen Liu; Lanying Du; Shibo Jiang
Journal:  Rev Med Virol       Date:  2016-04-08       Impact factor: 6.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.